Legal Representation
Attorney
ROSEMARY S TARLTON
USPTO Deadlines
Application History
24 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 26, 2006 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Sep 26, 2006 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jan 24, 2006 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Nov 9, 2005 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Nov 1, 2005 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Oct 12, 2005 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Sep 13, 2005 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Sep 9, 2005 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Sep 7, 2005 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 6, 2005 | ZZZX | Z | PREVIOUS ALLOWANCE COUNT WITHDRAWN | Loading... |
| Aug 29, 2005 | PBCR | Z | WITHDRAWN FROM PUB - OG REVIEW QUERY | Loading... |
| Aug 9, 2005 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Aug 9, 2005 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jul 25, 2005 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jul 22, 2005 | ACEC | I | AMENDMENT FROM APPLICANT ENTERED | Loading... |
| Jul 5, 2005 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jul 5, 2005 | I | PAPER RECEIVED | Loading... | |
| Feb 7, 2005 | CNRT | F | NON-FINAL ACTION MAILED | Loading... |
| Feb 4, 2005 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jan 25, 2005 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 13, 2004 | DMCC | I | DATA MODIFICATION COMPLETED | Loading... |
| Dec 29, 2004 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Dec 13, 2004 | I | PAPER RECEIVED | Loading... | |
| Jun 28, 2004 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Biological chemical diagnostic test kits for clinical or medical laboratory use, namely, for use in analysis of gene expression, genetics, single nucleotide polymorphism, haplotypes, proteins, and biological samples, for use in detecting diseases, for use in determining the progression of diseases, and for use in determining drug responses; diagnostic medical reagents, chemicals and solid matrix materials for biological, clinical or medical laboratory use for use in diagnosing inflammatory, infectious, central nervous system, cardiovascular, neurological, endocrine, autoimmune and genetic diseases, developmental disorders and cancer
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"REFERENCE LABORATORY"